Company Overview

Development Stage

About the Company

[Summary] Dedicated to the discovery and global development of targeted drugs an

We are one of China's innovative pharmaceutical research and development companies focused on the global market. Over the past 20 years, we have established a fully integrated R&D innovation platform with discovery and development capabilities. We currently have 13 clinical-stage innovative anti-cancer drugs undergoing clinical research globally, 12 of which were self-developed by us. Since our inception, we have advanced 13 self-discovered anti-tumor drug candidates into clinical studies worldwide, with the first three innovative oncology drugs now approved and launched - Elunate® (Fruquintinib capsules), Suzhou® (Surufatinib capsules), and Orpathys® (Savolitinib tablets).

We have also established a deep and profitable commercial platform in the Chinese market, manufacturing, marketing, and distributing our self-developed innovative oncology drugs, as well as prescription drugs and consumer health products.

Hutchison MediPharma is listed on the NASDAQ Global Select Market, The Stock Exchange of Hong Kong, and the AIM market of the London Stock Exchange (NASDAQ/LSE: HCM; HKEX: 13).

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Hutchison MediPharma How Fast Is Hiring Growing? (227 open positions)

Manage
Note: How fast is hiring at Hutchison MediPharma (Shanghai) Co., Ltd. growing? Hutchison MediPharma2025: 293 openings (up 14%), 2024: 256 openings (up 30%), 2023: 197 openings (down 41%), 2022: 332 openings (down 52%), 2021: 694 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Hutchison MediPharma Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 50%
  • 2024: Up 47%
  • 2023: Down 40%
  • 2022: Down 19%
Hutchison MediPharma Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Hutchison MediPharma (Shanghai) Co., Ltd. growing? Hutchison MediPharmaMaster's recruitment over the years: 2025: 33 openings (up 50%), 2024: 22 openings (up 47%), 2023: 15 openings (down 40%), 2022: 25 openings (down 19%), 2021: 31 openings.

Hutchison MediPharma Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Hutchison MediPharma Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Hutchison MediPharma (Shanghai) Co., Ltd. growing? Hutchison MediPharmaDoctorate recruitment over the years: 2026: 5 openings (up 15%), 2024: 2 openings (up 47%), 2023: 1 openings (down 40%), 2022: 5 openings (down 19%), 2021: 6 openings.

Hutchison MediPharma R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Hutchison MediPharma (Shanghai) Co., Ltd.? Based on an analysis of Hutchison MediPharma's job postings over the past year, "医疗卫生/美容保健类" demand: 47.5%, "计算机/网络/技术类": 41.6%, "电子/电器/通信技术类": 6.7%, "生物/制药/化工/环保类": 5.9%, "其他(研发和技术类)": 4.8%, "机械/仪器仪表类": 2%. For reference only.

Hutchison MediPharma — What Are the Salaries Like? (539 records)

Manage
salary range: 2K - 50K, 59.7% of roles pay ¥10-30K
Note: salary statistics are based on 539 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Hutchison MediPharma (Shanghai) Co., Ltd.?Hutchison MediPharma59.7% of positions earn 10-30K, Fresh graduate salary: ¥3.0K。销售类 average salary ¥13.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Hutchison MediPharma

(More)
Are salaries high at Hutchison MediPharma (Shanghai) Co., Ltd.? We provide: 信息,医药代表,实习生,地区经理,qa,qc,产品经理,ma,oc,pr,高级经理,市场,ea,pm,te,ie,ir,ra,分析,合规. Click to view detailed salary analysis by job.

Hutchison MediPharma — Fortune 500? (More)

Hutchison MediPharma honors, qualifications & industry associations

Hutchison MediPharma Related Industry Tags

Job Category

  • 销售类
    47.1% of total 47.1%
  • 医疗卫生/美容保健类
    46.4% of total 46.4%
  • 计算机/网络/技术类
    40.2% of total 40.2%
  • 工厂生产类
    14.8% of total 14.8%

Education

  • 本科
    76.5% of total 76.5%
  • 不限
    11.3% of total 11.3%
  • 硕士
    7.8% of total 7.8%
  • 高中
    2.1% of total 2.1%

Experience

  • 5-10年
    26.8% of total 26.8%
  • 1-3年
    25.9% of total 25.9%
  • 不限
    21.3% of total 21.3%
  • 3-5年
    19.2% of total 19.2%
View Detailed Analysis

What does Hutchison MediPharma (Shanghai) Co., Ltd. require? Who is Hutchison MediPharma hiring? Hutchison MediPharma recruitment: 销售类占比最多占47.1%,其次是医疗卫生/美容保健类占46.4%. What education can get in at Hutchison MediPharma? 本科占比最多占76.5%,其次是不限占11.3%. High education required at Hutchison MediPharma? 硕士占7.8%,博士占0.9%. Work experience required at Hutchison MediPharma? 5-10年占比最多占26.8%,其次是1-3年占25.9%. Where are the job locations at Hutchison MediPharma? 上海占比最多占51.3%,其次是长沙占6.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 44,200万(美元)
Legal Representative: SU WEI-GUO
Date Established:
Credit Code: 91310115743282846Q
Registered Address: 中国(上海)自由贸易试验区蔡伦路720弄4号

Partners & Suppliers

澎立生物为和黄医药提供临床前药代动力学服务 Source
供应商 制药企业
和黄医药授予武田制药呋喹替尼在中国以外地区的开发及商业化独家许可,武田支付首付款、里程碑及销售分成。 Source
合作客户 VEGFR抑制剂合作开发
药明康德为和黄医药提供小分子药物外包服务 Source
供应商 制药公司客户
信达生物向和黄医药提供信迪利单抗用于联合呋喹替尼的临床试验。 Source
供应商 PD-1联合用药合作
君实生物向和黄医药提供特瑞普利单抗用于联合HMPL-689的临床试验。 Source
供应商 PD-1联合用药合作

People who follow Hutchison MediPharma also follow

Hutchison MediPharma Competitors (Similar Companies)

“Engaged in the research, development, production, distribution, and de”
“Continuously innovating to bring patients medicines that significantly”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Technology Cares for Life”
“Research, development, and production of anti-tumor and surgical medic”
“Provides consulting and services to over one hundred pharmaceutical ma”
“Specializing in providing automotive electronic product solutions and ”
“Pioneering innovation, benefiting patients”
“Nutritional health food provider”
“Discovery and development of innovative drugs, as well as clinical res”
“Writing memories with chips, letting the world's beauty last forever”
“Well-known brand in composite materials”
造影剂 非处方药 临床诊断 生产
“High-commitment, high-quality macromolecule drug CDMO technical servic”
医药 药物研发 生物医药 新药研发

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates